DPP6 and dementia: The results of our genomic, genetic, expression and modeling analyses, provide direct evidence to support the involvement of DPP6 loss in dementia, with loss of function variants (PTC, inversion) having a higher penetrance and disease impact and missense variants having a variable risk contributions to disease from high to low penetrance [56, 79].